File: '\\swfile\EmailIn\20260430 214653 Attachment PTHI NEWS RELEASE 31DEC2025.docx'

office: 416.287.3835

Pond Technologies | 8-250 Shields Court | Markham, Ontario L3R 9W7 | Canada

www.pondtech.com | @pondtechglobal | TSX:V POND

LEGAL*68757907.2

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.

Pond Technologies Holdings Inc. Announces Filing of

2025 Audited Consolidated Financial Statements and MD&A

Markham, Ontario April 30, 2026 - Pond Technologies Holdings Inc. (the "Company" or "Pond") (TSX.V: POND) announces the filing of the audited consolidated financial statements of the Company for the year ended December 31, 2025 and the related management's discussion and analysis which have been filed and are available for review on SEDAR+ at www.sedarplus.ca and on the Company's website at www.pondtech.com.

About Pond Technologies Holdings Inc.

Located in Markham, Ontario, Pond is a technology leader in controlled environment cultivation of microalgae. In over ten years of R&D, Pond has developed a robust disruptive technology platform based on artificial intelligence, proprietary LED lights, and patented CO2-Management. The use of concentrated CO2 from industrial waste streams enables Pond to boost the productivity of microalgae well beyond the capacity of outdoor algae growers and allows industrial emitters to abate and ultimately recycle CO2. Pond is currently selling microalgae-derived antioxidant astaxanthin under its Regenurex brand. As micro-algae are becoming increasingly important in pharmaceuticals and cosmetics, nutraceuticals, human nutrition, aqua farming, bioplastics and biofuels, Pond has begun to license its technology to third parties for ongoing license fees and royalties. Pond recently added a Biotech division focused on the growth of unique strains of micro-algae to be used as a reproductive medium for the expression of human anti-bodies and proteins.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accept responsibility for the adequacy or accuracy of this release.

For further information contact Grant Smith, Chief Executive Officer, at g.smith@pondtech.com, 416-287-3835 ext. 201; or Tracey St. Denis, Chief Financial Officer, at tstdenis@stdeniscpa.com.